Literature DB >> 28748279

[Invasive Candida infections in liver cirrhosis].

A Koch1, F Tacke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28748279     DOI： 10.1007/s00063-017-0328-3

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  8 in total

Review 1.  Management of the critically ill patient with cirrhosis: A multidisciplinary perspective.

Authors:  Mitra K Nadim; Francois Durand; John A Kellum; Josh Levitsky; Jacqueline G O'Leary; Constantine J Karvellas; Jasmohan S Bajaj; Andrew Davenport; Rajiv Jalan; Paolo Angeli; Stephen H Caldwell; Javier Fernández; Claire Francoz; Guadalupe Garcia-Tsao; Pere Ginès; Michael G Ison; David J Kramer; Ravindra L Mehta; Richard Moreau; David Mulligan; Jody C Olson; Elizabeth A Pomfret; Marco Senzolo; Randolph H Steadman; Ram M Subramanian; Jean-Louis Vincent; Yuri S Genyk
Journal:  J Hepatol       Date:  2015-10-28       Impact factor: 25.083

Review 2.  Clinical hepatotoxicity associated with antifungal agents.

Authors:  Ioannis Kyriakidis; Athanasios Tragiannidis; Silke Munchen; Andreas H Groll
Journal:  Expert Opin Drug Saf       Date:  2016-12-16       Impact factor: 4.250

Review 3.  The challenges of multi-drug-resistance in hepatology.

Authors:  Javier Fernández; Frédéric Bert; Marie-Hélène Nicolas-Chanoine
Journal:  J Hepatol       Date:  2016-08-17       Impact factor: 25.083

4.  Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessia Carnelutti; Elda Righi; Maria Merelli; Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Assunta Sartor; Pierluigi Toniutto; Joost Wauters; Wim Laleman; Carlo Tascini; Francesco Menichetti; Roberto Luzzati; Pierluigi Brugnaro; Alessio Mesini; Stefania Raviolo; Francesco G De Rosa; Leonel Lagunes; Jordi Rello; George Dimopoulos; Arnaldo L Colombo; Marcio Nucci; Antonio Vena; Emilio Bouza; Patricia Muñoz; Mario Tumbarello; Raffaella Losito; Ignacio Martin-Loeches; Claudio Viscoli
Journal:  Intensive Care Med       Date:  2017-03-07       Impact factor: 17.440

5.  Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.

Authors:  Henning W Zimmermann; Alexander Koch; Sebastian Seidler; Christian Trautwein; Frank Tacke
Journal:  Liver Int       Date:  2011-10-17       Impact factor: 5.828

Review 6.  [Management of decompensated liver cirrhosis in the intensive care unit].

Authors:  O Lerschmacher; A Koch; K Streetz; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-14       Impact factor: 0.840

7.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

8.  Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

Authors:  Rajiv Jalan; Javier Fernandez; Reiner Wiest; Bernd Schnabl; Richard Moreau; Paolo Angeli; Vanessa Stadlbauer; Thierry Gustot; Mauro Bernardi; Rafael Canton; Agustin Albillos; Frank Lammert; Alexander Wilmer; Rajeshwar Mookerjee; Jordi Vila; Rita Garcia-Martinez; Julia Wendon; José Such; Juan Cordoba; Arun Sanyal; Guadalupe Garcia-Tsao; Vicente Arroyo; Andrew Burroughs; Pere Ginès
Journal:  J Hepatol       Date:  2014-02-12       Impact factor: 25.083
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.